blog/
59 pages · Updated 2026-09-24
Pages
- EXTEDO Announces New Regional Partnership with Egypt for Information Dissemination | EXTEDO
- EXTEDO Expands its Global Reach in Pakistan | EXTEDO
- Choosing an ISO/IEC 27001 certified service provider: Advantages for companies and organizations | EXTEDO
- European Medicines Agency (EMA): Quarterly System Demos 2026 | EXTEDO
- The EMA prepares itself for Brexit | EXTEDO
- Upcoming Changes in eCTD EU Module 1 Specification | EXTEDO
- Mandatory Use of eCTD for New DMF Submissions in Canada | EXTEDO
- Pharmacovigilance in a No-Deal Brexit Scenario | EXTEDO
- eCTD Related Guidelines for US FDA and EU | EXTEDO
- The Mystery of the EU IG - Insider Perspective | EXTEDO
- Interview: Meet EXTEDO’s eCTDtemplates! | EXTEDO
- New Requirements for Electronic Submission of Drug Master Files (DMFs) | EXTEDO
- EXTEDO Experts sharing their Expertise - Where to Meet Them | EXTEDO
- The National Health Regulatory Authority in Kingdom of Bahrain chooses EXTEDO´s EURS solution for validation & reviewing | EXTEDO
- What are the Differences between eCTD v3 and eCTD v4? - A Comprehensive Guide | EXTEDO
- EU eCTD M1 Specification v3.1.1 and Validation Criteria v8.2 | EXTEDO
- WHO goes eCTD - All you need to know | EXTEDO
- 5 Ways Cloud-based Computing is Changing Business | EXTEDO
- Bertelsmann Investments Announces Another Major Investment in the Growing Pharma Tech Market | EXTEDO
- The Challenges of Implementing a Regulatory Information Management (RIM) System | EXTEDO
- Why we believe in IDMP, and you should too | EXTEDO
- What is eCTD 4.0? | EXTEDO
- The Drivers and Benefits behind eCTD 4.0 | EXTEDO
- Glossary of Regulatory Abbreviations | EXTEDO
- EXTEDO Innovation Days & User Group Meetings replaced by virtual meetings | EXTEDO
- Key Concepts Behind eCTD 4.0 and their Impact on Product Submissions | EXTEDO
- Updated Version of the HMA eSubmission Roadmap (v2.2) Available | EXTEDO
- Gens & Associates IDMP Vendor Assessment & Capability Survey - How does MPDmanager powered by CARA compare to competing products? | EXTEDO
- What is eCTD? - The story of the electronic Common Technical Document | EXTEDO
- US FDA Adverse Event Reporting System (FAERS) Electronic Submissions | EXTEDO
- European eCTD Module 1 v3.0: What to expect & how to prepare? | EXTEDO
- Updated notification method for QPPV and PSMF updates to MHRA (Replacing eCTD sequence submission requirement) | EXTEDO
- Submission Platforms in EU and Further Changes | EXTEDO
- The European Medicines Agency (EMA) comes to Amsterdam | EXTEDO
- EXTEDO Opens New Office in Shanghai | EXTEDO
- EMA PMS Info Day 2026: The Future of Data-Driven Medicines Regulation in Europe | EXTEDO
- US FDA Adopts ICH Clinical Trials Guideline with Exclusive Reference to E2B(R3) Standards | EXTEDO
- EXTEDO上海分公司成立！ | EXTEDO
- How to Outsource Your eCTD Submission Publishing: What to Look for in a Vendor | EXTEDO
- EMA's December Updates Unwrapped! | EXTEDO
- EXTEDO & Wrike announce strategic partnership to release a planning and tracking solution for the life sciences industry | EXTEDO
- New Guidance on Handling of DCP/MRP | EXTEDO
- EU IDMP Implementation Guide Version 1 Released | EXTEDO
- New EU General Data Protection Regulation (GDPR) | EXTEDO
- EXTEDO Announces New Regional Partnership with Inpharmatis for the Baltic and CIS region | EXTEDO
- EU Medical Device Regulation 2020 - What You Need to Know | EXTEDO
- 3 Vital Cloud Migration Considerations | EXTEDO
- eCTD v4: Understanding the New Language of Regulatory Submissions | EXTEDO
- The Sticky Note of Regulatory Compliance: Why STFs Still Matter | EXTEDO
- Australia readies itself for eCTD only | EXTEDO
- EMA Publishes New Timeline For DADI Project | EXTEDO
- Egyptian Drug Authority Moves Forward with Digital Transformation: Phase II Agreement Signed with EXTEDO and DAF | EXTEDO
- Validation – Part II: Validation Criteria in Regulatory Processes | EXTEDO
- What is IDMP? | EXTEDO
- EMA Extends PMS Deadlines and Launches New PMS Functionalities for MAHs | EXTEDO
- EXTEDO Expands its Global Reach in South America | EXTEDO
- EMA Officially Endorses the New EudraVigilance System for Adverse Reactions | EXTEDO
- 中国药品监督管理局（CDA）开始要求使用eCTD标准 | EXTEDO
- What are the benefits of eCTD 4.0? | EXTEDO